다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Scientific reports, v.6, 2016년, pp.32495 -
Coleman, Samantha K. (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada) , Rebalka, Irena A. (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada) , D’Souza, Donna M. (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada) , Deodhare, Namita (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada) , Desjardins, Eric M. (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada) , Hawke, Thomas J. (McMaster University, Department of Pathology and Molecular Medicine , Hamilton, ON, L8S 4L8, Canada)
AI-Helper
While Type 1 Diabetes Mellitus (T1DM) is characterized by hypoinsulinemia and hyperglycemia, persons with T1DM also develop insulin resistance. Recent studies have demonstrated that insulin resistance in T1DM is a primary mediator of the micro and macrovascular complications that invariably develop ...
Forbes J. M. & Cooper M. E. Mechanisms of diabetic complications . Physiol. Rev. 93 , 137 – 188 ( 2013 ). 23303908
Livingstone S. J. et al. Scottish diabetes research network epidemiology group; Scottish renal registry. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010 . JAMA 313 , 37 – 44 ( 2015 ). 25562264
Yki-Järvinen H. & Koivisto V. A. Natural course of insulin resistance in type I diabetes . N. Engl. J. Med. 315 , 224 – 230 ( 1986 ). 3523247
Kilpatrick E. S. , Rigby A. S. & Atkin S. L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the diabetes control and complications trial . Diabetes Care 30 , 707 – 712 ( 2007 ). 17327345
Martin F. I. & Stocks A. E. Insulin sensitivity and vascular disease in insulin-dependent diabetics . Br. Med. J. 2 , 81 – 82 ( 1968 ). 5646096
Cleland S. J. , Fisher B. M. , Colhoun H. M. , Sattar N. & Petrie J. R. Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia 56 , 1462 – 1470 ( 2013 ). 23613085
Donga E. , Dekkers O. M. , Corssmit E. P. & Romijn J. A. Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis . Eur. J. Endocrinol. 173 , 101 – 109 ( 2015 ). 25899581
Amiel S. A. , Sherwin R. S. , Simonson D. C. , Lauritano A. A. & Tamborlane W. V. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes . N. Engl. J. Med. 315 , 215 – 219 ( 1986 ). 3523245
P-eltoniemi P. et al. Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin-resistant skeletal muscle of patients with type 1 diabetes . Diabetes 50 , 1371 – 1377 ( 2001 ). 11375338
Schauer I. E. et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study . Diabetes 60 , 306 – 314 ( 2011 ). 20978091
Nadeau K. J. et al. Insulin resistance in adolescents with type 1 diabetes and Its relationship to cardiovascular function . J. ClinEndocr. Metab. 95 , 513 – 521 ( 2010 ).
Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle . Endocr. Metab. Immune Disord. Drug Targets. 7 , 65 – 74 ( 2007 ). 17346204
Wullaert A. , van Loo G. , Heyninck K. & Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond . Endocr. Rev. 28 , 365 – 386 ( 2007 ). 17431229
Kaneto H. et al. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes . Curr. Mol. Med. 7 , 674 – 686 ( 2007 ). 18045145
Laakso M. & Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development . Nat. Rev. Endocrinol. 10 , 293 – 302 ( 2014 ). 24663222
Martin F. I. R. & Warne G. L. Factors influencing the prognosis of vascular disease in insulin-deficient diabetics of long duration: a seven-year follow-up . Metabolism 24 , 1 – 9 ( 1975 ). 1167391
Martin F. I. R. & Hopper J. L. The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus . Diabetologia 30 , 149 – 153 ( 1987 ). 3556289
Erbey J. R. , Kuller L. H. , Becker D. J. & Orchard T. J. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population . Diabetes Care 21 , 610 – 614 ( 1998 ). 9571351
Roglic G. et al. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM complications study . Diabet. Med. 15 , 418 – 426 ( 1998 ). 9609365
Purnell J. Q. , Zinman B. & Brunzell J. D. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC) study . Circulation 127 , 180 – 187 ( 2013 ). 23212717
Specht B. J. et al. Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes . J. Pediatr. 162 , 297 – 301 ( 2013 ). 22921593
Martin F. I. & Stocks A. E. Insulin sensitivity and vascular disease in insulin-dependent diabetics . Br. Med. J. 2 , 81 – 82 ( 1968 ). 5646096
McPherron A. C. , Lawler A. M. & Lee S. J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member . Nature 387 , 83 – 90 ( 1997 ). 9139826
Brandt C. et al. Plasma and muscle myostatin in relation to type 2 diabetes . PLoS One 7 , e37236 ( 2012 ). 22615949
Hulmi J. J. , Silvennoinen M. , Lehti M. , Kivelä R. & Kainulainen H. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy . Am. J. Physiol. Endocrinol. Metab. 302 , E3007 – E3015 ( 2012 ).
Sriram S. et al. Myostatin induces DNA damage in skeletal muscle of streptozotocin-induced type 1 diabetic mice . J. Biol. Chem. 289 , 5784 – 5798 ( 2014 ). 24425880
Jeong J. , Conboy M. J. & Conboy I. M. Pharmacological inhibition of myostatin/TGF-β receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes . Acta. Pharmacol. Sin. 34 , 1052 – 1060 ( 2013 ). 23770987
Wang Q. , Guo T. , Portas J. & McPherron A. C. A soluble activin receptor type IIb does not improve blood glucose in streptozotocin-treated mice . Int. J. Biol. Sci. 11 , 199 – 208 ( 2015 ). 25561902
Cleasby M. E. et al. Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal . Am. J. Physiol. Endocrinol. Metab. 306 , E814 – E823 ( 2014 ). 24473441
Guo T. et al. Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy . Diabetes 61 , 2414 – 2423 ( 2012 ). 22596054
Guo T. et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity . PLoS One 4 , e4937 ( 2009 ). 19295913
Zhao B. , Wall R. J. & Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance . Biochem. Biophys. Res. Commun. 337 , 248 – 255 ( 2005 ). 16182246
Wilkes J. J. , Lloyd D. J. & Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance . Diabetes 58 , 1133 – 1143 ( 2009 ). 19208906
Krause M. P. et al. Diabetic myopathy differs between Ins2Akita+/− and streptozotocin-induced type 1 diabetic models . J. Appl. Physiol. 106 , 1650 – 1659 ( 2009 ). 19246652
Armstrong R. B. , Gollnick P. D. & Ianuzzo C. D. Histochemical properties of skeletal muscle fibers in streptozotocin-diabetic rats . Cell Tissue Res. 162 , 387 – 394 ( 1975 ). 126806
Klueber K. M. & Feczko J. D. Ultrastructural, histochemical, and morphometric analysis of skeletal muscle in a murine model of type I diabetes . Anat. Rec. 239 , 18 – 34 ( 1994 ). 8037375
Girgenrath S. , Song K. & Whittemore L. A. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow-and fast-type skeletal muscle . Muscle Nerve 31 , 34 – 40 ( 2005 ). 15468312
Amthor H. et al. Lack of myostatin results in excessive muscle growth but impaired force generation . Proc. Natl. Acad. Sci. USA 104 , 1835 – 1840 ( 2007 ). 17267614
Hennebry A. et al. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression . Am. J. Physiol. Cell Physiol. 296 , C525 – C534 ( 2009 ). 19129464
Wang M. Y. et al. Leptin therapy in insulin-deficient type I diabetes . Proc. Natl. Acad. Sci. USA 107 , 4813 – 4819 ( 2010 ). 20194735
Zhang C. et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice . Diabetologia 55 , 183 – 193 ( 2012 ). 21927895
Shan T. , Liang X. , Bi P. & Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle . Faseb j. 27 , 1981 – 1989 ( 2013 ). 23362117
Chen Y. , Cao L. , Ye J. & Zhu D. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin . Biochem. Biophys. Res. Commun. 388 , 112 – 116 ( 2009 ). 19646957
Wieteska-Skrzeczynska W. , Grzelkowska-Kowalczyk K. , Jank M. & Maciejewski H. Transcriptional dysregulation of skeletal muscle protein metabolism in streptozotocin-diabetic mice . J. Physiol. Pharmacol. 60 , 29 – 36 ( 2009 ). 19609011
Laing S. P. et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes . Diabetologia 46 , 760 – 765 ( 2003 ). 12774166
Dorman J. S. et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study: mortality results . Diabetes 33 , 271 – 276 ( 1984 ). 6698317
Lehto S. , Rönnemaa T. , Pyörälä K. & Laakso M. Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy . Arterioscler. Thromb. Vasc. Biol. 19 , 1014 – 1019 ( 1999 ). 10195930
Rodrigues T. C. et al. Obesity and coronary artery calcium in diabetes: the coronary artery calcification in type 1 diabetes (CACTI) study . Diabetes Technol. Ther. 13 , 991 – 996 ( 2011 ). 21770813
Lach-Trifilieff E. et al. Treatment of sporadic inclusion body myositis with bimagrumab . Neurology 83 , 2239 – 2246 ( 2014 ). 25381300
Yu X. , Park B. H. , Wang M. Y. , Wang Z. V. & Unger R. H. Making insulin-deficient type 1 diabetic rodents thrive without insulin . Proc. Natl. Acad. Sci. USA 105 , 14070 – 14075 ( 2008 ). 18779578
Tobinick E. L. The value of drug repositioning in the current pharmaceutical market . Drug News Perspect 22 , 119 – 125 ( 2009 ). 19330170
Bujak A. L. et al. AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging . Cell Metab. 21 , 883 – 890 ( 2015 ). 26039451
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.